Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02985060Phase 2Unknown
Phase 2, randomised, open-label trial in ischemic stroke (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Favorable outcome at 3 months and Mortality at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02985060.